 STAMFORD, Conn., Sept. 06, 2022 GLOBE NEWSWIRE -- Cara Therapeutics, Inc. Nasdaq: CARA, a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference on Tuesday, September 13, 2022, at 8:30 a.m. ET. 